Erratum to 'Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?': [Trends in Endocrinology & Metabolism 26 (2015) 643-656]

Published Erratum

. 2016 Jan;27(1):65.

doi: 10.1016/j.tem.2015.11.006. Epub 2015 Nov 30.

Affiliations

¹ Department of Endocrinology, University of Ioannina, Stavros Niarchos Avenue, 45110, Ioannina, Greece.
² Department of Endocrinology, University of Ioannina, Stavros Niarchos Avenue, 45110, Ioannina, Greece. Electronic address: atsatsou@uoi.gr.

Published Erratum

Athanasios Fountas et al. Trends Endocrinol Metab. 2016 Jan.

. 2016 Jan;27(1):65.

doi: 10.1016/j.tem.2015.11.006. Epub 2015 Nov 30.

¹ Department of Endocrinology, University of Ioannina, Stavros Niarchos Avenue, 45110, Ioannina, Greece.
² Department of Endocrinology, University of Ioannina, Stavros Niarchos Avenue, 45110, Ioannina, Greece. Electronic address: atsatsou@uoi.gr.

No abstract available

Erratum for

Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?
Fountas A, Diamantopoulos LN, Tsatsoulis A. Fountas A, et al. Trends Endocrinol Metab. 2015 Nov;26(11):643-656. doi: 10.1016/j.tem.2015.09.003. Epub 2015 Oct 19. Trends Endocrinol Metab. 2015. PMID: 26492832 Review.

Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice.
Choung S, Kim JM, Joung KH, Lee ES, Kim HJ, Ku BJ. Choung S, et al. PLoS One. 2019 Feb 8;14(2):e0210828. doi: 10.1371/journal.pone.0210828. eCollection 2019. PLoS One. 2019. PMID: 30735525 Free PMC article.